Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Options in HIV therapy: present and future].

J Röling1, R Draenert, F D Goebel

  • 1Medizinische Poliklinik - Innenstadt, Klinikum der Ludwig-Maximilians-Universität München, Germany.

Der Internist
|June 22, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The impact of antibiotic stewardship interventions and patient related factors on antibiotic prescribing in a vascular surgical department.

Infection·2023
Same author

[23/f-Recurrent diarrhea : Preparation for the medical specialist examination: part 38].

Der Internist·2021
Same author

[80/m-dyspnea and increasing confusion : Preparation for the medical specialist examination: part 18].

Der Internist·2021
Same author

[36/f-Fever and pain in the right arm : Preparation for the medical specialist examination: part 15].

Der Internist·2021
Same author

Measles, mumps, rubella and VZV: importance of serological testing of vaccine-preventable diseases in young adults living with HIV in Germany.

Epidemiology and infection·2016
Same author

Novel antibiotics: are we still in the pre-post-antibiotic era?

Infection·2015

Highly active antiretroviral therapy (HAART) has reduced HIV deaths, but drug resistance necessitates new treatments. Research is exploring novel targets and compounds to improve HIV therapy and protect uninfected cells.

Area of Science:

  • Virology
  • Pharmacology
  • Immunology

Context:

  • Highly active antiretroviral therapy (HAART) has significantly reduced HIV-related mortality.
  • Current HAART regimens combine drugs from four classes: nucleoside reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors, protease inhibitors, and fusion inhibitors.
  • Increasing drug resistance necessitates the development of new antiretroviral compounds and therapeutic strategies.

Purpose:

  • To explore novel targets for antiretroviral therapy based on a deeper understanding of HIV replication.
  • To identify potential strategies for protecting uninfected cells from HIV infection.
  • To inform the development of improved and next-generation antiretroviral treatments.

Summary:

  • HAART has been effective but faces challenges due to emerging drug resistance.

Related Experiment Videos

  • Understanding HIV's molecular mechanisms reveals new potential targets for intervention.
  • Inhibiting extracellular binding mechanisms offers a strategy to protect uninfected cells.
  • Developing novel drug classes and improving existing therapies are crucial for advancing HIV treatment.

    • Impact:

    • Advances in understanding HIV replication can lead to the identification of novel therapeutic targets.
    • New antiretroviral drugs and drug classes will enhance treatment options for HIV patients.
    • Protecting uninfected cells could represent a significant breakthrough in HIV prevention and management.
    • Continued research will enrich the landscape of antiretroviral treatment, improving patient outcomes.